Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins

Clinical trial NCT06262685 · UNKNOWN

Trial details

NCT number: NCT06262685
Sponsor: Instituto de Investigación Hospital Universitario La Paz
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiovascular Diseases Dyslipidemias Statin Adverse Reaction Pharmacogenic Myopathy

Start date: 2024-03-04
Primary completion: 2025-02-10
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.